ImmunityBio Inc (NASDAQ: IBRX) Hogging The Spotlight Today
The Vanguard Group, Inc. recently announced the acquisition of new stake in ImmunityBio Inc (NASDAQ:IBRX). The institutional investor has increased its shareholding in the Healthcare company by 43.20% to 14.37 million shares with purchase of 4.34 million shares. This fresh investment now brings its stake to 2.15% valued currently at $72.15 million. In addition, BlackRock […]
Are Analysts Expecting A Better 2020 For ImmunityBio Inc (IBRX)?
ImmunityBio Inc (IBRX) concluded trading on 01/11/24 at a closing price of $3.97, with 3.41 million shares of worth about $13.53 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.04% during that period and on Thursday the price saw a loss of about […]
